HuGE Literature Finder
Records
1
-
1
PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab. Lung cancer (Amsterdam, Netherlands) 2020 Nov . Wang Haiyong, Shan Qinge, Guo Jun, Han Xiao, Zhao Chenglong, Li Huijuan, Wang Zheh |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: